Business Wire

CO-WESTERN-UNION

22.6.2021 12:02:05 CEST | Business Wire | Press release

Share
Western Union Releases 2020 Environmental, Social and Governance (ESG) Report

The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today released its 2020 Environmental, Social and Governance (ESG) Report , spotlighting the company’s commitment to its stakeholders through an evolved ESG strategy and actions aligned to its key ESG priorities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210622005354/en/

“2020 reinforced the importance of collective action to address global challenges,” said Hikmet Ersek, Western Union’s President and CEO. “Following a year in which borders were sealed and economies struggled, we emerged with an even sharper focus on our role as a connector of people and businesses globally. Our ESG efforts are closely aligned to this view of our business, and our belief that we have a critical role to play in creating solutions and building collaborations worldwide to advance shared ESG priorities.”

2020 ESG Highlights

The report outlines the company’s efforts to connect people and businesses globally, foster an inclusive workplace, move money with integrity, uphold strong governance, safeguard our shared environment, and provide training, education and crisis relief through the Western Union Foundation. Key accomplishments in these areas included:

  • Cross-border money movement : Enabling nearly 150 million customers in more than 200 countries and territories to send and receive funds in more than 130 currencies, to and from almost anywhere, as the global pandemic raged.
  • Support for migrants: Continuing to support migrant, refugee and other vulnerable populations through monetary and other support to organizations focused on these groups, raising awareness and funding critical research.
  • Fraud prevention: Preventing $1.4 billion of fraudulent transactions, with the lowest annual dollar-value payout reported as fraud since Western Union began tracking consumer fraud claims in 2005.
  • Board diversity: Actively ensuring diversity at Board level - as of 2020, 45% of the company’s 11 Board members were female and/or identified as Latinx, Asian or LGBTQ+.
  • Human rights: Identifying and prioritizing the company’s human rights impacts, and releasing a Human Rights Statement guided by internationally recognized standards.
  • Western Union Foundation: Enabling the Western Union Foundation to reach more than 200,000 people through workforce skilling and support for resilience in crises.

Western Union’s ESG Strategy and Goals

In 2020, Western Union completed a refreshed materiality assessment to further shape its ESG strategy and priorities. This process identified 21 ESG topics to be integrated into Western Union’s ESG efforts, prioritizing three topics of greatest importance to its business and stakeholders: furthering economic prosperity around the world ; promoting the integrity of global money movement; and advancing diversity, equity, and inclusion (DEI).

The company also set forth the following goals to continue advancing its ESG priorities:

  • Maintain gender pay equity globally and racial/ethnic pay equity in the U.S.
  • Increase gender diversity in leadership, achieving at least 40% women in senior management positions by 2025.
  • Increase racial and ethnic diversity among employees, including reaching at least 25% Latinx and Black employees in the U.S. by 2025.
  • Conduct more than 300,000 partner engagements, such as compliance program reviews or trainings, with Western Union partners globally to continue building capacity within the financial system to detect and prevent illicit activity, by 2025.
  • Reach approximately 300 million consumers and clients to promote fraud awareness and education by 2025.

The Western Union 2020 ESG report and executive summary are available for download at https://corporate.westernunion.com/esg/ . It is prepared in accordance with Global Reporting Initiative (GRI) standards, and includes responses to select relevant metrics from the Sustainability Accounting Standards Board (SASB) Standards. The report also details Western Union’s actions to advance the United Nations Sustainable Development Goals.

Safe Harbor Compliance Statement for Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements are not historical facts or guarantees of future outcomes, but rather are based on current expectations, estimates, assumptions, and projections, and include statements regarding our goals, commitments, programs, and other plans and objectives. Words such as “expects,” “intends,” “targets,” “goals,” “anticipates,” “believes,” “estimates,” “aims,” “plans,” “strives,” and other similar expressions or future or conditional verbs such as “may,” “will,” “should,” “would,” “could,” and “might” are intended to identify such forward-looking statements. Our actual outcomes and results may differ materially from those expressed in, or implied by, our forward-looking statements based on changes in circumstances, assumptions not being realized, or other risks, uncertainties, and factors. Such risks, uncertainties, and factors include, but are not limited to, those discussed in the Risk Factors section throughout our Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q and Current Reports filed on Form 8-K with the U.S. Securities and Exchange Commission. In addition, we cannot assure you that outcomes or results, including the achievement of any stated goals or targets, will have the forecasted, desired, or expected consequences and effects. Our forward-looking statements are only as of the date they are made, and we undertake no obligation to update any forward-looking statement.

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Western Union’s platform provides seamless cross-border flows and its leading global financial network bridges more than 200 countries and territories and over 130 currencies. We connect businesses, financial institutions, governments, and consumers through one of the world’s widest reaching networks, accessing billions of bank accounts, millions of digital wallets, and cards, and over half a million retail locations. Western Union connects the world to bring boundless possibilities within reach. For more information, visit www.westernunion.com .

WU-G

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release

Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release

IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release

Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye